How Remote Collaboration Platforms Helped the Life Sciences Thrive During the Pandemic
Recorded on Thursday, May 6, 2021 | Apprentice.io

Life science technology leaders will discuss how Apprentice.io’s pharma-compliant remote collaboration platform helped them steady supply chains, better manage operations, and increase speed to market during the pandemic. Hear about how the adoption of this platform helped their teams successfully navigate manufacturing challenges and ultimately deliver safer, more reliable drug products, treatments and therapies – from COVID to cancer. Register now.

Accelerate Time-to-Value of Clinically Rich Healthcare Data
Recorded on Wednesday, May 5, 2021 | Prognos Health

Learn how Prognos Health and Datavant are transforming & improving the way life sciences can access an extensive network of integrated real world data sources to define an ideal patient cohort as well as key demographic, therapeutic & customer insights. Register now.

Using new technologies to expand biomarker discovery efforts
Recorded on Tuesday, May 4, 2021 | BD

This Fierce webinar will feature executives from leading biopharma companies and technology-development firms, who will describe the latest tools and techniques for improving biomarker discovery. They will discuss how they chose and deployed these technologies, provide examples of how they led to the discovery of novel biomarkers, and offer tips for selecting tools to aid in biomarker discovery and incorporating them into established R&D processes. Register Today

How Sensors Are transforming Clinical Trials

Sensors are transforming clinical trials by providing a 24/7 stream of objective insights into the health of patients. Sponsors, sites and most importantly patients all benefit from sensors, and use of the devices was on the rise even before COVID-19 turbocharged adoption. Yet, the nascent, fast-moving sensor sector poses challenges. Sponsors that navigate those challenges will be richly rewarded with clinical trials that generate new insights at record speeds. Download now.

Speed to IND - Supercharge clinical readiness with a development partner
Recorded on Thursday, April 15, 2021 | Miltenyi Biotec

Biotechnology companies of all sizes face many challenges in the development of new cell and gene therapies. In this webinar, Mike O’Mara and Dr. Ian Gaudet will introduce the development and manufacturing approach used by Miltenyi Biotec and describe how a CDMO partner focused in process and analytical development can enable clinical readiness. Register Now.

Where to Innovate in OTC
Recorded on Tuesday, April 13, 2021 | Catalent

In 2020, consumers purchased over-the-counter (OTC) medicine heavily in March, but then shifted their consumption to vitamins and dietary supplements (VMS) for the remainder of the year. In this webinar, Catalent partnered with NielsenIQ to bring forward new insights that provide starting points for re-establishing growth via innovation in the OTC market. Save Your Spot - Register Now.

Contract management: How automated systems are unburdening life sciences legal teams

At each step in the product life cycle, pharma, biotech and medtech companies need to engage with third parties to develop, manufacture and sell their drugs, diagnostics and devices. With lives at stake and multiple players pursuing opportunities, companies that close deals quickly have a competitive edge. Yet, each contract exposes a company to an array of major third-party risks, creating a need for systems that support both speed and quality. Download this playbook to learn more.

The role of antibody testing as a companion test to SARS-CoV-2 vaccination
Recorded on April 1, 2021 | Abingdon Health

Attend this webinar to learn about the role neutralising antibody testing plays in antibody detection, response to mass vaccination, longevity of immunity to SARS-CoV-2, and examine performance characteristics data. Register now. 

Spotlighting COVID-19 Vaccination and Delayed Care Trends
Recorded on Tuesday, March 30, 2021 | Definitive Healthcare

COVID-19 has resulted in delayed care across specialties. Join us as we discuss returning to pre-pandemic clinical activity and strategies that biopharma organizations are using to engage HCPs. Register now.

Key Insights Into Developing High Concentration Formulations
Integrity Bio, Inc.

As the field of protein therapeutics pushes into higher and higher concentration space, unique challenges that require creative solutions are becoming more evident. Drawing from a combined 40 years of biologics formulation experience, we have distilled key takeaways from high concentration development into this whitepaper. Download now. 

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes
Recorded on Wednesday, March 24, 2021 | IPM.ai

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM, a rare, life-threatening neuromuscular disease, affecting about 1 in 40-50,000 newborn males. The session will review how IPM.ia and Audentes collaborated to uncover the XLMTM patient population. Register now.

Multiple Myeloma Insights from KOL Investigators
Recorded on Tuesday, March 23, 2021 | Precision for Medicine

March Is Multiple Myeloma Month. In recognition of this important month, join us for a Precision Key Opinion Leader (KOL) Insights series webinar. You’ll hear from two leading investigators on the lessons learned, current trends, and insights relevant to the Multiple Myeloma (MM) US and EU research community. Dr. Paul Richardson and Dr. Maria-Victoria Mateos have collectively published >700 papers and both have been recognized for excellence in MM research. This is a rare opportunity to get a look into current MM treatment. Register Now.

Industry Perspective: Defining the Optimal Clinical Supply Strategy for Cell/Gene Therapy Studies
Recorded on Monday, March 22, 2021 | Catalent

Cell, gene-modified cell and gene therapies hold the promise to offer new hope and novel therapeutic avenues for individuals facing serious illnesses and medical conditions. But bringing these therapies successfully through the clinical trial process introduces a level of supply chain risk, complexity and specialized requirements which are not yet fully understood. This webinar focuses on taking a closer look at unique clinical supply challenges and unique needs associated with cell and gene therapies. Register Now.

Drug Design and the Patient Journey

Patient-focused drug design can be a key factor in real-world therapeutic outcomes and business success. But if successful treatments should be created with patients in mind, when is the optimal time to solicit this feedback? And, what are the best methods for interacting with patients during drug development? This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Download Now.

Age-Appropriate Formulation Development for Pediatric Trials-Challenges and Considerations

In this webinar, industry experts discuss the recent advances, challenges and considerations in pediatric drug development. Real-life examples presented by the experts illustrate the impact of age-appropriate dose forms for pediatrics and highlight insights into the caregiver perspectives. Watch the webinar to learn about a case study on real-world medications and acceptability assessment. Download Now.

Patient-Focused Drug Design: Through the Lens of Real-World Case Studies, Clinical Evidence and Advanced Delivery Solutions

The incorporation of patient-focused drug design principles early in the development cycle is critical to developing safe and effective treatments that address the specific needs of target patient populations in-terms of appropriateness, preference and usability. Download this webinar to discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes.

Lost in Translation: Moving Your Research to Clinical Trials
Recorded on Wednesday, March 17, 2021 | STEMCELL Technologies

Scaling up research procedures into clinical-scale manufacturing of new cellular therapeutics presents a challenge for many academic facilities. Join Drs. Adrian Gee and David McKenna in this live webinar for a discussion about the issues to be addressed when translating your cell and gene therapy research to the clinic; from picking your team to finding an effective culture system and beyond. Register Now.

Navigating the rapidly evolving regulatory environment for gene and cell therapies
Recorded on Tuesday, March 16, 2021 | CMIC

The FDA has hired more than 50 new reviewers in anticipation of receiving 200 applications per year from companies hoping to start clinical trials of gene and cell therapies and issuing 10 to 20 new approvals a year by 2025. This webinar will review the latest developments in the regulatory review process for gene and cell therapies, offering advice that companies can use to streamline their interactions with regulators, both in the U.S. and overseas. Register Now.

Enabling Individuals to Act on Heart Health Insights
Recorded on Wednesday, March 10, 2021 | Evidation Health

In this webinar, a panel of experts -- representing patient advocacy, cardiology, pharmaceutical, and health technology -- will discuss approaches for empowering individuals with heart conditions to act on best insights tailored to their specific situation (in a permissioned manner). Register Now.

Using DSaaS to Drive Innovation in Life Sciences
Recorded on Wednesday, March 10, 2021 | Change Healthcare and Amazon Web Services (AWS)

Leaders discuss how Data Science as a Service (DSaaS) can empower life sciences organizations to tackle critical healthcare issues. Register now.

Paid Marketplace
The Importance of Proactive Clinical Returns Planning

Accurate and timely delivery of clinical trial supplies helps to ensure that a study’s timeline stays on track. Sponsors often focus on upfront planning to ensure sites are prepared to reach clinical milestones but ignore the logistical challenges of reconciling and destroying clinical returns. Download this Article to learn about the top 3 clinical returns considerations for sponsors, how to anticipate requirements for clinical returns, and how country specific requirements can impact reverse logistics.

Paid Marketplace
Implementing a Stability Strategy for Short Expiry IMPs

Different clinical trials have different supply needs and strategies. Download this free Q&A article to learn about stability strategy for clinical trials, the importance of supply chain communication, automated control systems and country-specific labeling protocols.

Paid Marketplace
9 Questions You Need To Ask About Clinical Supply

Planning on using a CRO to support your next clinical study? Here are the top 9 questions you should always ask to help your CRO or partner of choice better understand your clinical supply needs. Download this Infographic to learn more.

Simplify Your Supply Chain in the Race to Phase I
Recorded on Tuesday, March 9, 2021 | Thermo Fisher Scientific

Pharmaceutical companies face numerous hurdles during early development, from API manufacturing to drug product formulation to clinical supply logistics. Join Thermo Fisher Scientific experts to learn how a simplified supply chain may help increase efficiency and reduce risk as you move to your Phase I milestone. Register Now.

Facilitating Remote Site Monitoring Through Streamlined, Secure Content Exchange

In this paper, Box will discuss how life sciences organizations can adapt to the new environment and propel therapies and medical devices through the value chain by rethinking content exchange. This paper will explain how cloud technologies accelerate the verification of documents and patient records at clinical trial sites, provide real-time access to regulated and non-regulated content, boost productivity and ensure GxP compliance to facilitate remote site monitoring. Download now

Paid Marketplace
Remarque Systems Resource Hub
Remarque Systems

One single integrated solution that connects clinical trial data by centralizing all data sources, without the complexity of using multiple separate components. Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info

Expedited US FDA Development and Approval Programs for Serious Conditions
Recorded on Wednesday, March 3, 2021 | Rho

The US FDA’s Breakthrough Therapy Designation, Regenerative Medicine Advanced Therapy Designation, Accelerated Approval Program, Priority Review, and Fast Track Designation can reduce your product’s development and approval timelines if pursued at the optimal time and implemented appropriately. Successfully navigate US FDA’s expedited programs for development of products for serious conditions:  Understand the data expectations, planning and timing skills, and authoring strategies to optimize the chance of securing an expedited program designation. Register Now.

Gene therapy - Building processes around patients
Recorded on Thursday, February 25, 2021 | Vineti

Cell and gene therapies are placing the patient at the center of the supply chain in a vastly new way, with implications for production, financial operations, product ordering, logistics and patient access and support. With these high-value therapies gaining more acclaim and moving from academic treatment centers to community care, their therapeutic and commercial success will be more highly scrutinized. Register Now!

Leveraging cloud infrastructure technology to drive innovation in Pharma and Life Sciences
Recorded on Wednesday, February 24, 2021 | Nutanix

Join LabCorp and Nutanix for this one-hour webinar to learn how cloud infrastructure technology platform is transforming the business. You will learn how a design partnership between LabCorp and Nutanix can have a long-lasting positive impact in elevating the role of IT teams to become the strategic business partners for the organization.

The Benefits of Pharmacist-Led Clinical Trials
Recorded on Tuesday, February 23, 2021 | RxE2

This webinar will focus on how a pharmacist-led clinical trial model impacts the six key areas most relevant to clinical trials in today’s COVID and Decentralized Clinical Trial environment: regulations, recruiting, diversity, clinical outcomes, data integrity, and clinical supply chain. Register Now.

Mapping the Pathway to Designing Successful Treatments
Recorded on Tuesday, February 23, 2021 | Catalent Pharma Solutions

Join this webinar to learn how an integrated dose form design strategy based on analyzing data from a molecule’s physicochemical properties, ADME/PK, manufacturability and stability, plus patient and market considerations can help in creating better treatments. Register Today!

Gene to GMP in 6 months: AbSci and KBI accelerate our timeline for cell line development through cGMP manufacturing
Recorded on Tuesday, February 16, 2021 | AbSci & KBI Biopharma

Are you looking for a higher-quality, faster-time to market manufacturing solution for your protein therapeutic? Webinar attendees will learn how AbSci and KBI’s partnership enables cell line development through bulk microbial GMP manufacturing in 6 months, using cutting edge cell line development and biomanufacturing technology. Register Now.

2021 Apollo Healthcare Predictions
Recorded on Thursday, February 4, 2021 | InCrowd

Every year we ask our physicians their views on the future of the healthcare industry. With so much disruption from COVID-19, this year’s global insights will provide a unique window into the minds of those professionals perhaps most tested by 2020 and their hopes and perspectives for 2021. Register Now!

What to Look for in an Informatics Platform for Life Sciences R&D

As modern life science R&D becomes more complex, variable, and fluid, organizations need informatics platforms that can keep up. Learn about the five essential capabilities of a life science R&D informatics platform in this whitepaper from Benchling. Download now

Strategies for the Optimal Scale-up & Tech Transfer of Oral Small Molecules
Recorded on January 27, 2021 | Catalent

The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program’s ultimate success. Join this webinar to hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program. Register Now.

Are Real-Time Gene Therapy Test Results Possible?
Recorded on January 26, 2021 | Catalent & LumaCyte

Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real-time. Join Catalent and LumaCyte to learn how label-free analysis can provide near real-time infectivity measurements for vaccines and viral-based gene therapies. Register Today.

Handle the Surge in Contact Center Volume in your Healthcare Organization Post Covid Vaccine Approval with Salesforce
Recorded on January 21, 2021 | Salesforce & NeuraFlash

The covid vaccine launch has created a vast amount of calls to healthcare organizations. To keep up, you need a solution that can be stood up in less than 30 days. Join NeuraFlash & Salesforce as we showcase how to get started today! Register now.

Compliantly Digitize Your Global Operations and Quality Process with a Remote Workforce
Recorded on January 21, 2021 | DocuSign

With the COVID-19 pandemic disrupting global supply chains and forcing many to work from home, life sciences organizations are under pressure to quickly adapt while adhering to rigorous compliance standards. Join industry experts as they discuss best practices. Register Now.

Vaccine revolution - Will the COVID-19 race change infectious disease R&D forever?
Recorded on January 20, 2021 | BD

With pandemic vaccines launching at record speeds, we talk with experts in infectious disease research to examine the lessons learned from the pandemic and how they might change future vaccine development. View On-Demand Now.

4 Keys to Connecting With Health Audiences

How can health brands better connect with their audiences? Research insights determined four key factors. Verywell explains why they matter and how investing in them can pay off for both users and brands. Download the infographic to learn more.

Lab Weighing, Quality Control, and Supporting Applications

One of the most critical elements in the quality control of pharmaceutical manufacturing is the use of lab balances and weighing equipment. When it comes to sample preparation and management, there is always the risk of error during measuring and weighing. Download the whitepaper to learn more.

Biotech: Eye-to-eye with a pandemic - Managing the reality and challenges of COVID-19
Samsung Biologics

Through this whitepaper, Samsung Biologics outlines the areas that were critical in adapting best practices for business management in dealing with the pandemic including employee safety, GMP compliance, supply chain management, and digital adaptation. Download now.

Digital Therapeutics: How cloud technology is enhancing patient experience and outcomes
Amazon Web Services

Digital Therapeutics are becoming increasingly important tools to drive meaningful improvements in patient outcomes and support the overall patient journey. Learn how life science organizations are leveraging cloud technology in the development and deployment of secure, low-latency digital therapeutic programs. Download the whitepaper.

Paid Marketplace
Meet Us at JP Morgan Healthcare Conference
Samsung Biologics

Samsung Biologics is a fully integrated CDMO offering state-of-art contract development, manufacturing, and laboratory testing services. We look forward to connecting with you at the conference, learn more about our innovative approaches to bring our client satisfaction to the next level.

For more, visit our website, and connect with us through [email protected]

COVID-19 Antibody Cell Line Development in 10 Days
Recorded on Thursday, December 17, 2020 | AbSci

AbSci’s Protein PrintingTM technology enables rapid E. coli SoluPro® cell line development for complex therapeutic proteins. We will detail our ability to go from gene to purified antibody in 10 days, including cell line construction, fermentation, purification, and protein characterization. Register Today!

Benefits of 5KL When Outsourcing Late-phase Biologics Drug Substance Manufacturing
Recorded on Thursday, December 17, 2020 | Thermo Fisher Scientific

During this webinar, attendees will learn about Thermo Fisher Scientific’s new 5KL bioreactor and how it benefits clients who outsource late-phase biologics drug substance manufacturing. An introduction of the 5KL bioreactor will be provided, as well as application data around performance and scalability, process economy comparison with traditional stainless steel bioreactors, and decision criteria that could be helpful in choosing between different cell culture strategies. Register Today.

Leveraging AI to Generate Breakthrough Ideas in Science
Doctor Evidence

Today's pharmaceutical professionals face increasing pressure to discover, position, and repurpose drugs more efficiently than ever before. Artificial intelligence (AI) technology now empowers scientists to directly harness data and evidence to triage idea generation and hypothesis testing. Download now!

Care, Compliance, and Compromise—Adherence in the COVID Era
Recorded on Wednesday, December 16, 2020 | InCrowd

InCrowd’s Care, Compliance, and Compromise—Adherence in the COVID Era webinar examines the challenges facing healthcare professionals (HCPs) and patients during COVID-19 as they try to ensure adherence, while limiting exposure. The research analyzes insights shared by oncologists, rheumatologists, endocrinologists, and dermatologists, among others. Register Now.

Paid Marketplace
Emerging Biotech Resource Center

A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule. Learn more.

Research Report: 2020 North America Customer Reference Data Survey

Accurate HCP data is more important than ever as pharma shifts to digital engagement. New research from Veeva reveals that 88% of reps are using digital channels to connect with customers. Read the report to understand the state of customer reference data and benchmark your organization’s progress.